Abbott Laboratories Q2 Earnings: Dividends Don't Lie

Group 1 - The article discusses Abbott Laboratories (ABT) and references a previous analysis from June 2024, indicating a positive alignment with Wall Street's views on the company [1] - Sensor Unlimited, the author, is an economist with a PhD, specializing in financial economics and has a decade of experience covering the mortgage market, commercial market, and banking industry [2] - The focus of the analysis includes asset allocation and ETFs related to the overall market, bonds, banking and financial sectors, and housing markets [2]